FDA: More issues reported with drugs from Massachusetts facility

Posted at 4:23 PM, Oct 15, 2012
and last updated 2012-10-15 20:45:58-04

(CNN) The Food and Drug Administration is reporting more problems with drugs from a Massachusetts compounding pharmacy, linked to a deadly outbreak of fungal meningitis.

Federal investigators say a patient with possible meningitis received an injection of a different product from the facility, not the steroid injection suspected of sickening hundreds of people and killing 15 more, including one person in Virginia.

Congressional leaders also say the New England Compounding Center received a warning letter in 2006 detailing violations by investigators. Then, last week, Massachusetts Governor Deval Patrick accused the compounding pharmacy of misleading regulators and operating outside its license by shopping batches of drugs nationwide.

Currently, the facility is only licensed to serve Massachusetts.

Meningitis is an inflammation of the protective membranes covering the brain and spinal cord. This specific type of meningitis is rare and, unlike viral and bacterial meningitis, not contagious.

Symptoms of meningitis include headache, fever, nausea and stiffness of the neck.